News
News
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK(TM) (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis...
News
Crypto Expo Asia Announces Partnerships with Asia Blockchain Association, Asia Blockchain Gaming Alliance, Asosiasi Blockchain Indonesia, Singapore Fintech Association, and More
News
Advanced Materials in Aerospace and Defence market is projected to grow at a CAGR of 5.3% by 2033: Visiongain